Q2 2022 Acasti Pharma Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Acasti Pharma Second Quarter 2022 Earnings Call. (Operator Instructions) It is now my pleasure to turn the floor over to your host, David Waldman of Investor Relations. Sir, the floor is yours.
Thank you, and good afternoon, everyone. I'd like to welcome you to Acasti Pharma's Fiscal 2022 Second Quarter Conference Call. On the call with us this afternoon are Jan D'Alvise, President and CEO; Dr. Pierre Lemieux, Chief Operating Officer, Canada; Chief Scientific Officer and Co-Founder; Dr. George Kottayil, Chief Operating Officer, U.S.; Brian Ford, Chief Financial Officer; and Prashant Kohli VP of Commercial Operations.
We are planning for a Q&A session at the end of our prepared remarks. But if you have any remaining questions after the call or would like any additional information about the company, please contact Crescendo Communications at (212) 671-1020. I'd also like to remind everyone that statements on this conference call
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |